Citadel Advisors
CDIOW icon

Citadel Advisors’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

Citadel Advisors’s Portfolio CDIOW Stock Details CDIOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,631
Closed -$454 – 14578
2024
Q3 		$454 Buy
+11,631
New +$438 ﹤0.01% 14017

Other funds holding CDIOW

BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.61% 1-Year Est. Return

Citadel Advisors's CDIOW Position: Q4 2024 in Review

Citadel Advisors sold out of Cardio Diagnostics Holdings Inc Warrant (CDIOW) in Q4 2024, closing a stake of 11,631 shares — an estimated $454 sold.

Citadel Advisors first reported a position in CDIOW in Q3 2024 and held it in 1 quarter. The position peaked at $454 in Q3 2024. 6 funds tracked by Wall St. Rank hold CDIOW as of Q4 2024.

  • Citadel Advisors reported no remaining Cardio Diagnostics Holdings Inc Warrant position as of Q4 2024 after selling out during the quarter.
  • Citadel Advisors sold 11,631 Cardio Diagnostics Holdings Inc Warrant shares in Q4 2024, an estimated $454.
  • Citadel Advisors first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q3 2024 and held it in 1 quarter.
  • Citadel Advisors's Cardio Diagnostics Holdings Inc Warrant position peaked at $454 in Q3 2024.
  • 6 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q4 2024.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.